{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:02:27Z","timestamp":1790002947821,"version":"4.0.1"},"reference-count":29,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,9,2]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>A woman in her 60s underwent uneventful sequential cataract surgeries for both eyes and achieved 6\/6 visual acuity postoperatively. 7 weeks after surgery, she developed bilateral cystoid macular oedema (CME) and her vision declined to a best-corrected visual acuity (BCVA) of 6\/21 in the right eye and 6\/24 in the left eye. She was diagnosed with bilateral Irvine-Gass syndrome (IGS). Initial treatment with topical steroids and non-steroidal anti-inflammatory drugs was ineffective. She was subsequently treated with a single dose of suprachoroidal triamcinolone acetonide (SCTA) injections (40 mg\/mL) in each eye. This intervention led to a rapid and complete resolution of CME within 2\u2009weeks. Her BCVA recovered to 6\/6 in both eyes and remained stable for 8\u2009months post-SCTA injections.<\/jats:p>\n                  <jats:p>This case highlights that SCTA may represent a promising treatment option for IGS, offering successful anatomical and functional outcomes in patients who do not respond to conventional topical therapy.<\/jats:p>","DOI":"10.1136\/bcr-2025-269913","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:15:36Z","timestamp":1790000136000},"page":"e269913","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of bilateral Irvine-Gass syndrome with suprachoroidal triamcinolone injection"],"prefix":"10.1136","volume":"19","clinical-trial-number":[{"clinical-trial-number":"nct02952001","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02595398","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8128-4927","authenticated-orcid":false,"given":"Fatima","family":"Zahra","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, The Aga Khan University Hospital, Karachi, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rashid","sequence":"additional","affiliation":[{"name":"The Aga Khan University Medical College, Karachi, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marium","family":"Anis","sequence":"additional","affiliation":[{"name":"The Aga Khan University Medical College, Karachi, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadijah","family":"Abid","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, The Aga Khan University Hospital, Karachi, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Tayyab","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, The Aga Khan University Hospital, Karachi, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"2026092107150808000_19.9.e269913.1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2147\/CIA.S111761","article-title":"Pseudophakic cystoid macular edema: update 2016","volume":"11","author":"Grzybowski","year":"2016","journal-title":"Clin Interv Aging"},{"key":"2026092107150808000_19.9.e269913.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2007.05.013"},{"key":"2026092107150808000_19.9.e269913.3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archopht.1966.03850010648005","article-title":"Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study","volume":"76","author":"Gass","year":"1960","journal-title":"Arch Ophthalmol Chic Ill"},{"key":"2026092107150808000_19.9.e269913.4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(53)90302-X"},{"key":"2026092107150808000_19.9.e269913.5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jcrs.2013.09.018","article-title":"Improving visual outcomes by preserving outer retina morphology in eyes with resolved pseudophakic cystoid macular edema","volume":"40","author":"Hunter","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"2026092107150808000_19.9.e269913.6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jcm10194375","article-title":"Current Management Options in Irvine-Gass Syndrome: A Systemized Review","volume":"10","author":"Orski","year":"2021","journal-title":"J Clin Med"},{"key":"2026092107150808000_19.9.e269913.7","doi-asserted-by":"publisher","DOI":"10.1097\/IIO.0b013e3181c551da"},{"key":"2026092107150808000_19.9.e269913.8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000430087","article-title":"A Case of Acute Bilateral Irvine-Gass Syndrome following Uncomplicated Phacoemulsification, Demonstrated with Optical Coherence Tomography","volume":"6","author":"Shields","year":"2015","journal-title":"Case Rep Ophthalmol"},{"key":"2026092107150808000_19.9.e269913.9","first-page":"1079","article-title":"Bilateral phakic cystoid macular edema associated with Crohn\u2019s disease","volume":"95","author":"Mason","year":"2002","journal-title":"South Med J"},{"key":"2026092107150808000_19.9.e269913.10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.survophthal.2025.11.001","article-title":"Pseudophakic macular edema: Review and new insights on treatment and prophylaxis","volume":"71","author":"Campos","year":"2026","journal-title":"Surv Ophthalmol"},{"key":"2026092107150808000_19.9.e269913.11","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2147\/TCRM.S271184","article-title":"Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema","volume":"16","author":"Giarmoukakis","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"2026092107150808000_19.9.e269913.12","first-page":"258","article-title":"Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome","volume":"12","author":"Guclu","year":"2019","journal-title":"Int J Ophthalmol"},{"key":"2026092107150808000_19.9.e269913.13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000365945","article-title":"Intravitreal injection of dexamethasone implant and ranibizumab in cystoid macular edema in the course of irvine-gass syndrome","volume":"5","author":"Fenicia","year":"2014","journal-title":"Case Rep Ophthalmol"},{"key":"2026092107150808000_19.9.e269913.14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/09273948.2014.898775","article-title":"Intravitreal Ranibizumab for the Treatment of Irvine-Gass Syndrome","volume":"23","author":"Mitropoulos","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"2026092107150808000_19.9.e269913.15","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1007\/s10792-020-01491-5","article-title":"Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study","volume":"40","author":"Sharma","year":"2020","journal-title":"Int Ophthalmol"},{"key":"2026092107150808000_19.9.e269913.16","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.37765\/ajmc.2023.89324","article-title":"Suprachoroidal triamcinolone acetonide injectable suspension for macular edema associated with noninfectious uveitis: an in-depth look at efficacy and safety","volume":"29","author":"Yeh","year":"2023","journal-title":"Am J Manag Care"},{"key":"2026092107150808000_19.9.e269913.17","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1007\/s10792-023-02856-2","article-title":"Suprachoroidal triamcinolone versus posterior subtenon triamcinolone either alone or formulated in the management of diabetic macular edema","volume":"43","author":"Tharwat","year":"2023","journal-title":"Int Ophthalmol"},{"key":"2026092107150808000_19.9.e269913.18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2147\/OPTH.S351853","article-title":"Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema","volume":"16","author":"Zakaria","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"2026092107150808000_19.9.e269913.19","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317560"},{"key":"2026092107150808000_19.9.e269913.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.01.006"},{"key":"2026092107150808000_19.9.e269913.21","doi-asserted-by":"crossref","unstructured":"Ghazanfar AS , Khowaja AH , Tayyab H . Effect of suprachoroidal triamcinolone on intraocular pressure: a systematic review and meta-analysis. Ther Adv Ophthalmol 2024;16. doi:10.1177\/25158414241228671","DOI":"10.1177\/25158414241228671"},{"key":"2026092107150808000_19.9.e269913.22","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1097\/IAE.0000000000000726","article-title":"Intravitreal corticosteroids in diabetic macular edema","volume":"35","author":"Yang","year":"2015","journal-title":"Retina"},{"key":"2026092107150808000_19.9.e269913.23","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.4103\/ijo.IJO_1788_21","article-title":"Safety and efficacy of suprachoroidal triamcinolone acetonide for the management of serous choroidal detachment prior to rhegmatogenous retinal detachment surgery: A Pilot study","volume":"70","author":"Kohli","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"2026092107150808000_19.9.e269913.24","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-023-02808-5","article-title":"Suprachoroidal triamcinolone acetonide for the treatment of macular edema associated with retinal vein occlusion: a pilot study","volume":"23","author":"Ali","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"2026092107150808000_19.9.e269913.25","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/24741264251365386","article-title":"Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response","volume":"9","author":"Bello","year":"2025","journal-title":"J Vitreoretin Dis"},{"key":"2026092107150808000_19.9.e269913.26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/meajo.meajo_78_21","article-title":"Single Low-dose Suprachoroidal Triamcinolone Acetonide Injection in Macular Edema Secondary to Noninfectious Posterior Uveitis","volume":"30","author":"Anand","year":"2023","journal-title":"Middle East Afr J Ophthalmol"},{"key":"2026092107150808000_19.9.e269913.27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/17469899.2022.2114456","article-title":"Triamcinolone acetonide injectable suspension for suprachoroidal use in the treatment of macular edema associated with uveitis","volume":"17","author":"Thomas","year":"2022","journal-title":"Expert Rev Ophthalmol"},{"key":"2026092107150808000_19.9.e269913.28","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-025-03972-6","article-title":"Efficacy of combined topical nepafenac 0.3% with suprachoroidal injection of triamcinolone acetonide using a modified custom needle in pseudopkakic cystoid macular edema","volume":"25","author":"Nawar","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"2026092107150808000_19.9.e269913.29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.5301\/EJO.2011.6506","article-title":"Bilateral cystoid macular edema after cataract surgery resolved by vitrectomy","volume":"21","author":"Scarpa","year":"2011","journal-title":"Eur J Ophthalmol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-269913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:15:40Z","timestamp":1790000140000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-269913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,21]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bcr-2025-269913"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-269913","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}